Related Experiment Video
Updated: May 10, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
Cobalamin C defect presenting with isolated pulmonary hypertension
Francesca G Iodice1, Luca Di Chiara, Sara Boenzi
1Unit of Pediatric Cardiac Anesthesia and Intensive Care, Department of Pediatric Cardiology and Cardiac Surgery, Children’s Hospital Bambino Gesù IRCCS, Rome, Italy. fgiovanna.iodice@opbg.net
Insights
Cobalamin C defect, a common vitamin B12 metabolism disorder, typically presents in early childhood. This case highlights isolated pulmonary hypertension as an unusual initial symptom in an unscreened child.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Cobalamin C (cblC) defect is the most prevalent inherited disorder affecting vitamin B12 metabolism.
- Clinical manifestations of cblC defect are diverse, ranging in severity and typically appearing in infancy or early childhood.
- Commonly presents as a multisystem disease with neurological, ocular, hematological, renal, and gastrointestinal involvement.
Purpose of the Study:
- To report a unique presentation of Cobalamin C defect.
- To expand the differential diagnosis for pulmonary hypertension in pediatric cases.
- To emphasize the importance of considering metabolic disorders even with atypical symptoms.
Main Methods:
- Case report of a 2-year-old boy.
- Detailed clinical evaluation focusing on presenting symptoms.
- Diagnostic workup for inherited metabolic disorders, specifically vitamin B12 metabolism.
Main Results:
- The patient presented with isolated pulmonary hypertension as the primary clinical feature.
- The patient had not undergone newborn screening for metabolic disorders.
- Subsequent diagnosis confirmed Cobalamin C defect as the underlying cause.
Conclusions:
- This case demonstrates an atypical presentation of Cobalamin C defect, with pulmonary hypertension as the leading symptom.
- The spectrum of inherited diseases causing pulmonary hypertension should include metabolic disorders like cblC defect.
- Highlights the diagnostic challenge in patients not identified through newborn screening programs.
Abstract:
Cobalamin C (cblC) defect is the most common inborn error of vitamin B12 metabolism. Clinical features vary as does the severity of the disease. In most cases, the clinical symptoms of cblC defect tend to appear during infancy or early childhood as a multisystem disease with severe neurologic, ocular, hematologic, renal, and gastrointestinal signs. The neurologic findings are common and include hypotonia, developmental delay, microcephaly, seizures hydrocephalus, and brain MRI abnormalities. We report a case of a young boy with cblC defect, who did not undergo newborn screening, presenting at the age of 2 years with isolated pulmonary hypertension as the leading symptom. This novel way of presentation of cblC defect enlarges the spectrum of inherited diseases that must be considered in the differential diagnosis of pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Vitamins
Cytomegalovirus Disease
Other Pulmonary Disorders
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
